Elements of the tumor microenvironment disrupt CD8-mediated immunity, which contributes to tumor immune escape [44] and peripheral blood of patients with HNSCC showed suppressive activity of regulatory T cells [45]. The gene discussed is CD8A; the disease is neoplasm.